" class="no-js "lang="en-US"> Pamela Tenaerts - Medtech Alert
Saturday, December 14, 2024
Pamela Tenaerts

Pamela Tenaerts

About Pamela Tenaerts

Dr. Tenaerts will lead the scientific office at Medable to drive advancement of decentralized research methodologies with evidence-based best practices. As Medable’s chief scientific officer, Dr. Tenaerts will lead evidence collection around patient centricity, efficiency and quality in decentralized trials. She will work with Medable’s existing science leaders to expand Medable’s digital biomarkers work with NIH and other partners. She will evolve best practices and bring clinical insight into Medable’s continued work on a master protocol approach to multi-study research. And with more than one million participants currently on the Medable platform, Dr. Tenaerts will create ways to keep participants engaged for potential future clinical trial participation.

Related Story

New Study: Decentralized Clinical Trials Can Achieve Net Financial Benefits of 5X to 14X, Due to Reduced Trial Timelines and Other Factors

January 14 2022

Medable Inc., the leading cloud platform for patient-centered drug development, today announced results from a […]